[PDF][PDF] Identification of high affinity non-peptidic small molecule inhibitors of MDM2-p53 interactions through structure-based virtual screening strategies

S Bandaru, D Ponnala, C Lakkaraju… - Asian Pacific Journal …, 2015 - researchgate.net
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an
important therapeutic strategy in resurrecting wild type p53 functional status. The present …

Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies.

S Bandaru, D Ponnala, C Lakkaraju… - Asian Pacific Journal …, 2015 - europepmc.org
Background Approaches in disruption of MDM2-p53 interactions have now emerged as an
important therapeutic strategy in resurrecting wild type p53 functional status. The present …

[PDF][PDF] Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies

S Bandaru, D Ponnala, C Lakkaraju, C Kumar… - Asian Pac J Cancer … - academia.edu
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an
important therapeutic strategy in resurrecting wild type p53 functional status. The present …

Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies

S Bandaru, D Ponnala, C Lakkaraju… - Asian Pacific journal of …, 2015 - dbpia.co.kr
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an
important therapeutic strategy in resurrecting wild type p53 functional status. The present …

Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies

S Bandaru, D Ponnala, C Lakkaraju… - Asian Pacific Journal …, 2015 - koreascience.kr
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an
important therapeutic strategy in resurrecting wild type p53 functional status. The present …

[PDF][PDF] Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies

S Bandaru, D Ponnala, C Lakkaraju… - … Pacific Journal of …, 2015 - pdfs.semanticscholar.org
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an
important therapeutic strategy in resurrecting wild type p53 functional status. The present …

[PDF][PDF] Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies

S Bandaru, D Ponnala, C Lakkaraju… - Asian Pacific Journal …, 2015 - researchgate.net
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an
important therapeutic strategy in resurrecting wild type p53 functional status. The present …

Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies

S Bandaru, D Ponnala, C Lakkaraju… - … Pacific journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Approaches in disruption of MDM2-p53 interactions have now emerged as an important
therapeutic strategy in resurrecting wild type p53 functional status. The present study …

Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies

S Bandaru, D Ponnala, C Lakkaraju… - Asian Pacific Journal …, 2015 - journal.waocp.org
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an
importanttherapeutic strategy in resurrecting wild type p53 functional status. The present …

[PDF][PDF] Identification of High Affinity Non-Peptidic Small Molecule Inhibitors of MDM2-p53 Interactions through Structure-Based Virtual Screening Strategies

S Bandaru, D Ponnala, C Lakkaraju… - Asian Pacific Journal …, 2015 - scholar.archive.org
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an
important therapeutic strategy in resurrecting wild type p53 functional status. The present …